Background : The association of apolipoprotein E (apoE) polymorphism with interindividual variability of serum lipid concentrations and the initiation and progression of atherosclerosis is inconclusive. This study was performed to explore the associations of apoE with lipid concentrations and ischemic stroke in patients with large artery atherosclerosis (LAA) subgroup or without atherosclerotic vascular lesions (small artery occlusion, SAO) subgroup through a case-control study among the Korean population.
INTRODUCTION
3, and 4, resulting in six common genotypes [1, 2] . ApoE 4 differs from 3 by a single amino acid substitution at codon 112 (Cys→Arg) and from 2 by a single amino acid substitution at codon 158 (Arg→Cys) [3] .
The apoE 3/ 3 genotype is predominant and the behavior of this form of apoE is accepted as the reference for all apoE-dependent functions. ApoE is known to play a central role in determining the metabolic fate of plasma lipoproteins and consequently of cholesterol [4] [5] [6] [7] and to result in interindividual variability in plasma total cholesterol (TC) and low density lipoprotein cholesterol (LDLc) [6] [7] [8] [9] [10] [11] [12] . It has been postulated that certain apoE alleles are risk factors for the initiation and/or development of atherosclerosis [13, 14] . However, there are much controversies in the literature with regard to the association of the apoE polymorphism with TC and LDLc levels and we still do not understand the mechanisms by which specific apoE alleles affect atherosclerosis.
Many investigators have reported an association between the 4 allele and ischemic stroke as they found a higher frequency of the 4 allele in patients with ischemic stroke than in healthy controls [3, [15] [16] [17] [18] . However, not all studies support this association between the 4 allele and ischemic stroke and there is still controversy over this point [1, [19] [20] [21] [22] [23] .
Therefore, the aims of this study were 1) to investigate whether apoE polymorphisms play a role in atherosclerosis by comparing the differences between ischemic stroke subgroups with or without atherosclerotic lesions, 2) to study the relationship of lipid profile with apoE polymorphism as a risk factor for vascular event in ischemic stroke group.
SUBJECTS AND METHODS

Ischemic stroke patients and controls
Subjects were recruited from the ischemic stroke patients that were admitted to the Department of Neurology of Kyung Hee University Hospital between January 2002 and April 2003. All patients had been diagnosed with ischemic stroke, clinically by history taking and laboratory examinations for the risk factors of vascular disease, and radiologically by magnetic resonance image and angiography. Patients with evidence of cardioembolism were excluded from this study. Finally, 194 ischemic stroke patients, aged 34 to 86 years, were enrolled in the ischemic stroke group. In order to investigate a potential association between apoE polymorphisms and ischemic stroke with atherosclerotic vascular lesion, the patients were classified into two subgroups. Classification was based on the Trial of Org 10172 in Acute Stroke Treatment criteria [24] : i) the large artery atherosclerosis (LAA) group in which subjects had atherothrombotic infarction with atherosclerotic vascular lesion in multiple or single vessels, ii) the small artery occlusion (SAO) group in which subjects were without atherosclerotic vascular lesions. Risk factors were carefully documented: sex, age, hypertension, diabetes, smoking, ischemic heart disease, and family history or past history of stroke.
The control group consisted of 168 age-matched healthy subjects who had visited the Health Examination Center and Neurology Out-patients Clinic. All selected individuals were free from hypertension, diabetes, atherosclerotic peripheral arterial disease, history of previous stroke and ischemic heart disease, and Alzheimer's disease and other degenerative diseases.
Written informed consent was obtained from all subjects, and the study was approved by the institution's research ethical committee.
Measurement of lipids
The lipid profile included the serum level of TC, LDLc, high density lipoprotein cholesterol (HDLc), and triglycerides (TG). Venous blood sampling for lipid profile test was performed in the morning after overnight fasting.
Especially in ischemic stroke patients, blood sampling for measurement of lipids was done 3 months after the stroke.
The lipid profiles were measured with an automated chemistry analyzer Hitachi 7600 (Hitachi, Tokyo, Japan).
ApoE genotyping using real time PCR and melting curve analysis
Genomic DNA was extracted and purified from 100 L of whole blood from each stroke patient and control subject, using an automated nucleic acid isolation and purification system (Magtration System 6GC; Precision System Science, Chiba, Japan) according to the manufacturer's instructions. ApoE genotyping was performed using a com- 
Statistical analysis
The differences between the ischemic stroke group and control group and between the LAA and SAO subgroups were compared by the chi-square test for nominal vari- 
RESULTS
Distribution of apoE genotypes and serum lipid concentrations
There were no significant differences in age and sex between the ischemic stroke and the control groups ( Table   1 ). The frequencies of apoE genotypes (and apoE carriers) in the control and ischemic stroke groups are shown in Table 1 . There were significant differences in the distribution of apoE genotype and apoE carriers between the ischemic stroke and control groups ( 2 =12.0, 4 d.f., P=0.02 and 2 =6.7, 2 d.f., P=0.04). The frequency of the 4 carriers was significantly higher in the ischemic stroke group (22.7%) than in the control group (11.9%) (P=0.01). However, the frequency of the 2 carriers showed no significant difference between the ischemic stroke (12.4%) and control groups (11.9%) (P=0.89). The adjusted LDLc concentration was significantly higher in the ischemic stroke group than in control group (P=0.04).
Though statistical significance was not found, the adjusted HDLc was apparently lower in the ischemic stroke group than in the control group.
There were no significant differences in the clinical characteristics such as sex, hypertension, diabetes, and smoking between the LAA and SAO subgroups ( 
The relationship between the apoE genotypes and the serum lipid concentrations
All over the total subjects (N=362), including the ischemic stroke group and the control group, apoE genotype had a significant relationship on LDLc concentration (P=0.01) ( Table 3 
DISCUSSION
Many studies have been aimed at characterizing the relationship between apoE polymorphisms and atherosclerosis and ischemic stroke, and it has been postulated that certain apoE alleles (particularly the 4 allele) are risk factors for the initiation and/or development of atherosclerosis [13, 14] . However, the exact mechanism by which the apoE gene influences atherosclerosis remains unclear, and there is still much controversy over the putative association between ischemic stroke and the 4 allele. Generally, the 4 allele has been known to be associated with high TC and LDLc levels [6] [7] [8] [9] [10] [11] [12] and the 4 carriers have been known more likely to develop atherosclerosis [25, 26] .
However, the association of the 4 allele with elevated LDLc levels has not been observed in all studies [15] [16] [17] .
These inconsistent relationships between apoE and ischemic stroke and between apoE and serum lipid concentrations are probably due to differences in ethnicity, age, and sex distribution in the study group, diagnostic criteria, and environmental factors (e.g., diet, smoking, and drug therapy) [20] . The ethnic and geographical difference is a factor that leads to the inconsistent association between apoE and ischemic stroke. When limited to East Asia, the allele frequencies of 2, 3, and 4 are 3.5%, 85.1%, and 11.2 %, respectively, in the Japanese population [9, 27] , and are 8.4%, 85.2%, and 6.4%, respectively, in the Chinese population [9, 28] . Age in particular is known to influence apoE allelic frequencies within a population as a confounding factor. Many studies have shown that there is a stronger correlation between ischemic stroke and the apoE 4 allele in younger populations than in older ones [3, 15, 19, 29] .
Although there was a selection bias of the ischemic stroke group due to the exclusion of patients who died in the acute stage of ischemic stroke, our study revealed that the distribution of apoE genotypes was significantly different between the ischemic stroke group and the control group. The genotype 3/ 4 and the 4 carriers were significantly more frequent (P<0.05) in the ischemic stroke group than in the control group. However, there were no differences in the distribution of apoE genotypes (or apoE carriers) between the LAA and SAO subgroups with different pathogenesis of ischemic stroke. In addition, the ischemic stroke group had a higher LDLc concentration than the control group, but there were no differences in LDLc concentration between the LAA subgroup with atherosclerotic lesion and the SAO subgroup without atherosclerotic lesion. Besides, our study showed that the 2 carriers had a lower LDLc concentration than 3 and 4 alleles, but did not show that the 4 carriers had a higher LDLc concentration than 3 allele. These findings are consistent with the study of Shin et al. [30] performed on general population (not on ischemic stroke patients).
These findings suggest that although there was an apparent association between the 4 allele and ischemic stroke and between the LDLc concentration and ischemic stroke, the 4 allele may have other effects on ischemic stroke that are independent of atherosclerosis due to a high lipid concentration.
Though the serum lipid concentrations used in this study were not always representative values to reflect the basic status of the subjects because there was no consideration of confounding effect such as lipid-lowering therapy and relatively small sample size of the 4 carriers, it can be postulated that the 4 allele has no effect on serum lipid concentrations. Therefore, we can postulate other possibilities as to how apoE is involved in the development of ischemic stroke. First, apoE is a factor that is produced in response to neural injury and repair and may influence ischemic stroke by increasing susceptibility to brain injury or by impairing repair mechanisms associated with the presence of the 4 allele [18] . Second, the apoE genotype may influence the inflammatory response and modulate the risk of acute events by influencing plaque progression and rupture [20] .
Because of the complex and multifactorial nature of ischemic stroke, the effect of single apoE polymorphisms on the risk of stroke may be weak when analyzed individually and may result in a false association between apoE and ischemic stroke. Therefore, when evaluating the 
